KOE:200670

Humedix Co., Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:41 UTC

Last close

n/aKRW

Market data

4.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
30.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
21.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

361

2016-12-31 to 2025-12-31100 at the start361

Sales: 100.00 on 2016-12-31 to 360.79 on 2025-12-31, up 261%.

Profit

504

2016-12-31 to 2025-12-31100 at the start504

Profit: 100.00 on 2016-12-31 to 504.01 on 2025-12-31, up 404%.

Shares in issue

116

2016-12-31 to 2025-12-31100 at the start116

Shares in issue: 100.00 on 2016-12-31 to 115.78 on 2025-12-31, up 16%.

Sales is at 361, Profit is at 504, Shares in issue is at 116, against 100 in 2016.

Sales is at 361, Profit is at 504, Shares in issue is at 116, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100361
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit, where the first year is 100504
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Shares in issue, where the first year is 100116
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW